Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Bell

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|January 10, 2014
Remote ischaemic conditioning and ischaemic heart diseaseRobert M Bell
Statistics in Medicine|February 4, 2006
Improved hypothesis testing for coefficients in generalized estimating equations with small samples of clustersDaniel F McCaffrey, Robert M Bell
Cardiovascular Therapeutics|July 22, 2010
There is more to life than revascularization: therapeutic targeting of myocardial ischemia/reperfusion injuryRobert M Bell, Derek M Yellon
Journal of Molecular and Cellular Cardiology|February 28, 2003
Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOSRobert M Bell, Derek M Yellon
Journal of Molecular and Cellular Cardiology|April 24, 2012
Conditioning the whole heart--not just the cardiomyocyteRobert M Bell, Derek M Yellon
Journal of the American College of Cardiology|February 11, 2003
Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathwayRobert M Bell, Derek M Yellon
Interventional Cardiology Clinics|June 6, 2017
Implications of Kidney Disease in the Cardiac PatientRoger Rear, Pascal Meier, Robert M Bell
Expert Opinion on Pharmacotherapy|May 19, 2012
Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapyVikram Sharma, Robert M Bell, Derek M Yellon
Journal of Molecular and Cellular Cardiology|June 11, 2002
PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioningMihaela M Mocanu, Robert M Bell, Derek M Yellon
The Journal of Biological Chemistry|August 20, 2003
Functional analysis of a phosphatidic acid binding domain in human Raf-1 kinase: mutations in the phosphatidate binding domain lead to tail and trunk abnormalities in developing zebrafish embryosSujoy Ghosh, Sean Moore, Robert M Bell, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Hospital Medicine (London, England : 2005)|January 10, 2014
Remote ischaemic conditioning and ischaemic heart diseaseRobert M Bell
Statistics in Medicine|February 4, 2006
Improved hypothesis testing for coefficients in generalized estimating equations with small samples of clustersDaniel F McCaffrey, Robert M Bell
Cardiovascular Therapeutics|July 22, 2010
There is more to life than revascularization: therapeutic targeting of myocardial ischemia/reperfusion injuryRobert M Bell, Derek M Yellon
Journal of Molecular and Cellular Cardiology|February 28, 2003
Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOSRobert M Bell, Derek M Yellon
Journal of Molecular and Cellular Cardiology|April 24, 2012
Conditioning the whole heart--not just the cardiomyocyteRobert M Bell, Derek M Yellon
Journal of the American College of Cardiology|February 11, 2003
Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathwayRobert M Bell, Derek M Yellon
Interventional Cardiology Clinics|June 6, 2017
Implications of Kidney Disease in the Cardiac PatientRoger Rear, Pascal Meier, Robert M Bell
Expert Opinion on Pharmacotherapy|May 19, 2012
Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapyVikram Sharma, Robert M Bell, Derek M Yellon
Journal of Molecular and Cellular Cardiology|June 11, 2002
PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioningMihaela M Mocanu, Robert M Bell, Derek M Yellon
The Journal of Biological Chemistry|August 20, 2003
Functional analysis of a phosphatidic acid binding domain in human Raf-1 kinase: mutations in the phosphatidate binding domain lead to tail and trunk abnormalities in developing zebrafish embryosSujoy Ghosh, Sean Moore, Robert M Bell, et al.
Pageof 3